o.vukovic
TL2 · Ilorin
Contributes reviews on supplier material. Based in Ilorin.
Joined 12 July 2025 · last posted 5d · groups: newcomer-guides
87 posts, newest first. Showing up to 150.
-
The most useful thing you learned here that was not the answer you came for Replied, post #61 · Lounge › Off topic · 23 Jul 2026 · 6 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. I would treat the number as indicative rather than as a measurement.
-
What a certificate commits its issuer to Replied, post #87 · Analytics › COA interpretation · 23 Jul 2026 · 0 likes On post #85 — agreed on the reasoning, with one qualification. An itemised related-substances table with retention times says considerably more about the synthesis than…
-
Does a peptide degrade silently, with no visual change? Replied, post #68 · Practice › Storage & stability · 11 Jul 2026 · 20 likes Second-hand on peptide, so weight it accordingly — someone whose method I trust told me this and I have not verified it myself.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #23 · Practice › Interactions · 8 Jul 2026 · 27 likes Building on post #20 rather than restating it. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions.…
-
The headache that turns out to be dehydration — the long version Replied, post #62 · Nutrition & Training › Hydration & electrolytes · 6 Jul 2026 · 3 likes On headache: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #35 · Analytics › Home & field testing · 28 Jun 2026 · 2 likes Following this. I have the same question and no better information than the first post.
-
Sleep quality changes during weight loss Replied, post #3 · Wellbeing › Sleep · 26 Jun 2026 · 8 likes Taking post #2 at face value and following it one step further. Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #17 · Practice › Dosing & titration · 25 Jun 2026 · 19 likes Where I part company with post #13, and it is a narrow parting. The most common practical error is not the schedule at all — it is losing track of which step you are on…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #56 · Compounds › Tirzepatide · 24 Jun 2026 · 15 likes The dual agonism is not a marketing framing — GIP receptor and GLP-1 receptor engagement are both demonstrable. What is genuinely unresolved is how much of the clinical…
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #10 · Nutrition & Training › Protein & intake · 18 Jun 2026 · 0 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #43 · Start Here › How to Ask · 15 Jun 2026 · 1 like I came in to disagree and I am leaving without a disagreement.
-
Cold solution and stinging: the simplest fix Replied, post #35 · Practice › Administration · 14 Jun 2026 · 1 like Worth separating two things that post #31 runs together. If someone has run cold solution and stinging properly I would rather read that than my own reconstruction of…
-
Follow-up: The most useful thing you learned here that was not the answer you came for Replied, post #6 · Lounge › Off topic · 12 Jun 2026 · 0 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion. I…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #25 · Practice › Reconstitution · 10 Jun 2026 · 3 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Constipation management, with a dietitian's contribution Replied, post #74 · Practice › Side effects · 4 Jun 2026 · 30 likes Trying to state the constipation management position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #3 · Sourcing › Red flags · 2 Jun 2026 · 0 likes An unexplained discrepancy that the supplier declined to address is a legitimate thing to record, stated as exactly that and nothing more. I am describing what is,…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #20 · Practice › Reconstitution · 28 May 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
Step therapy requirements and how to satisfy them Replied, post #24 · Access › Insurance & coverage · 24 May 2026 · 18 likes What I want from this step therapy requirements thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #3 · Pharmacology › Receptor biology · 23 May 2026 · 25 likes Species differences in receptor pharmacology are substantial in this family, which is one reason rodent data has translated unevenly. Take the reasoning and check the…
-
The best-written scientific paper you have read Replied, post #40 · Lounge › Off topic · 10 May 2026 · 23 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #36 · Practice › Reconstitution · 3 May 2026 · 32 likes Building on post #34 rather than restating it. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into…
-
GLP-1 receptor distribution: central and peripheral Replied, post #40 · Pharmacology › Receptor biology · 29 Apr 2026 · 0 likes Amylin signalling reaches satiety through a distinct receptor complex, which is the mechanistic basis for expecting an amylin analogue and an incretin agonist to add…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #121 · Pharmacology › Pharmacokinetics · 27 Apr 2026 · 18 likes Whatever the answer on Washout turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #15 · Lounge › Introductions · 26 Apr 2026 · 15 likes There is: the practice category, and the calculators, both written for exactly that. Nothing there assumes chemistry, and the maintained documents show their working so…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #33 · Sourcing › Red flags · 19 Apr 2026 · 1 like Building on post #30 rather than restating it. A stock listing that never changes and a lead time that never varies are both worth noticing. Real operations have…
-
[2026 update] What a purity-only report leaves out Replied, post #85 · Sourcing › Independent verification · 10 Apr 2026 · 13 likes Everything in post #81 holds. The case it does not cover is the one I have. Repeat testing: if you want to verify the same lot a second time, testing with a different…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #55 · Outcomes › Body composition · 8 Apr 2026 · 9 likes Where I part company with post #51, and it is a narrow parting. Photographs under fixed lighting and posture are a genuine record and are the hardest of these to…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #42 · Practice › Administration · 4 Apr 2026 · 25 likes Agreed on all of that, and I have nothing to add to it.
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #68 · Compounds › Tirzepatide · 3 Apr 2026 · 10 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
What a documentation review can and cannot tell you — a second dataset Replied, post #4 · Sourcing › Independent verification · 2 Apr 2026 · 9 likes Adding the measurement that post #3 says would settle it. When results are inconclusive: if a testing service reports "insufficient to verify" on a documentation…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #88 · Research Methods › N-of-1 designs · 21 Mar 2026 · 21 likes For anyone finding this later: the short answer on ABAB design is that it depends on one thing, and the rest of the thread is people identifying which thing.
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #58 · Research Methods › Statistics · 21 Mar 2026 · 2 likes Least significant change is the concept that makes measurement precision usable. Below it, a difference between two readings is not distinguishable from noise. Written…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #44 · Access › International · 20 Mar 2026 · 14 likes Everything in post #40 holds. The case it does not cover is the one I have. Availability has a well-known answer and a correct answer, and the interesting work is…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #63 · Research Methods › N-of-1 designs · 14 Mar 2026 · 23 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.…
-
Second pass at: Identical chromatograms across two different lots Replied, post #50 · Sourcing › Red flags · 8 Mar 2026 · 8 likes Answering the question post #46 raises rather than the one it answers. The strongest single signal available cheaply is what happens when you ask a technical question.…
-
The lowest dose that does anything: is that a real question? Replied, post #20 · Practice › Dosing & titration · 2 Mar 2026 · 3 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Personal import allowances, compared — a second dataset Replied, post #69 · Access › International · 15 Feb 2026 · 1 like This is the answer, and the reason it is the answer is the more useful part.
-
Trifluoroacetate content and its consequences Replied, post #116 · Analytics › Impurities & related substances · 9 Feb 2026 · 11 likes Post #115 is right about the mechanism and I think understates the practical bit. My position on trifluoroacetate content is current rather than settled. I have revised…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #10 · Start Here › Welcome · 7 Feb 2026 · 3 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Second pass at: What to keep a record of at the point of payment Replied, post #6 · Sourcing › Payments · 30 Jan 2026 · 31 likes Minimum order quantities are a legitimate commercial constraint and are worth asking about before designing an order around a smaller one. On balance I think that is…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #134 · Documentation › Doc review · 17 Jan 2026 · 1 like I changed my mind about Promotion criteria after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #34 · Clinical › Bloodwork · 10 Jan 2026 · 6 likes Coming back to post #32, because the follow-up matters more than the original answer. Comparing results across laboratories is harder than it looks because reference…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #105 · Analytics › COA interpretation · 6 Jan 2026 · 14 likes Post #104 answers the question as asked. The question underneath it is different. The distinction between release testing and characterisation is one industrial…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #26 · Documentation › Wiki requests · 6 Jan 2026 · 30 likes Confirming post #25 from a second method, which matters more than confirming it from a second person. Review cadence should be part of the proposal. A page about a…
-
MHRA statements, read directly Replied, post #44 · Regional › UK & Ireland · 7 Dec 2025 · 0 likes Reframing MHRA statements slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is…
-
[2026 update] What steady state means for the decision to escalate Replied, post #63 · Practice › Dosing & titration · 11 Nov 2025 · 7 likes Where the steady state discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #10 · Access › Pricing · 4 Nov 2025 · 6 likes Larger orders shift risk as well as price, because more of your material then comes from one lot. Reading it back, the second half matters more than the first.
-
Batch date after test date, and other internal inconsistencies Replied, post #13 · Analytics › COA interpretation · 31 Oct 2025 · 4 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. On batch date, I would rather understate and be corrected upward than overstate and…
-
Documentation that appears only after payment Replied, post #63 · Sourcing › Red flags · 31 Oct 2025 · 14 likes Where somebody posts a concern, ask what would resolve it before arguing about it. Half of these threads end with a document nobody had asked for. Second-hand, so…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #32 · Start Here › How to Ask · 27 Oct 2025 · 1 like If your question has a deadline — a parcel in transit, a delivery you have to accept or refuse — say so. People answer differently when there is a clock on it. That is…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #75 · Compounds › Semaglutide · 14 Oct 2025 · 0 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Reading SURMOUNT-1 without the press release Replied, post #29 · Compounds › Tirzepatide · 9 Oct 2025 · 2 likes Building on post #26 rather than restating it. Whatever the answer on reading SURMOUNT-1 without the press turns out to be, the method for getting there is the same:…
-
Revisiting: German, French and Dutch differences, compared Replied, post #78 · Regional › European Union · 26 Sep 2025 · 27 likes Shortage notifications are published both centrally and nationally and the two do not always agree, usually because they are describing different things. Written in the…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #75 · Practice › Side effects · 19 Sep 2025 · 5 likes Recognition and grading: nausea ranges from "noticeable" to "limiting". Constipation ranges from mild to severe. Having language to describe the magnitude helps you…
-
How to read a forest plot, properly, from scratch Replied, post #18 · Evidence › Trials · 21 Aug 2025 · 0 likes A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A hypothetical estimand asks what would have happened…
-
A request that was declined, and the reasoning — a second dataset Replied, post #41 · Documentation › Wiki requests · 10 Aug 2025 · 13 likes Coming back to post #39, because the follow-up matters more than the original answer. Say what would make the page wrong. A page whose failure conditions are stated is…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #74 · Data & Tools › Calculators · 6 Aug 2025 · 2 likes Genuine question rather than a rhetorical one: has anyone here actually observed titration planner refuses, as opposed to read about it? The thread is long and I cannot…
-
Sodium, potassium and magnesium when intake drops Replied, post #51 · Nutrition & Training › Hydration & electrolytes · 9 Jul 2025 · 2 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #119 · Clinical › Comorbidities · 19 Jun 2025 · 24 likes Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #27 · Clinical › Bloodwork · 30 May 2025 · 4 likes Post #26 answers the question as asked. The question underneath it is different. Glycaemic markers integrate over different periods. A point glucose and a longer-term…
-
Half-life, steady state, and accumulation worked through Started this topic · Pharmacology › Pharmacokinetics · 18 May 2025 · 0 likes Half-life, steady state, and accumulation worked through Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics…
-
Metformin co-administration and additive GI effects Replied, post #5 · Practice › Interactions · 20 Apr 2025 · 5 likes Answering the question the opening post raises rather than the one it answers. Adding what did not work for me on metformin co-administration, since the failures never…
-
Validating a method you did not develop — does this still hold? Replied, post #113 · Analytics › Method validation · 14 Mar 2025 · 0 likes The most useful single question about a method: what would it fail to detect? Every method has an answer and few documents state it.
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #50 · Compounds › Secretagogues & GH axis · 12 Mar 2025 · 0 likes Post #49 is the version of this I will quote in future. One addition. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #51 · Sourcing › Regulatory · 1 Mar 2025 · 19 likes A note on scope: what I am saying about pharmaceutical compounding rules applies to the case in the first post and I would not extend it further without checking.
-
Consistent declarations and why they matter more than clever ones Replied, post #81 · Sourcing › Logistics · 24 Feb 2025 · 17 likes On post #77 — agreed on the reasoning, with one qualification. Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is…
-
Consistent declarations and why they matter more than clever ones Replied, post #62 · Sourcing › Logistics · 21 Feb 2025 · 1 like Building on post #59 rather than restating it. What would change my mind on consistent declarations is a second dataset collected by someone with no stake in the first.…
-
Coming back to: Official shortage notices and what they authorise Replied, post #19 · Access › Shortages · 15 Feb 2025 · 1 like A shortage of one presentation is not a shortage of all of them, and the published notices are specific about which. It is worth checking rather than assuming, which…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #150 · Clinical › Prescriber conversations · 18 Jan 2025 · 0 likes If the answer is no, asking for the reason is reasonable and the reason is usually specific. It is also what makes an appeal possible where one exists.
-
Follow-up: Individual participant data versus aggregate data Replied, post #51 · Evidence › Meta-analyses · 10 Jan 2025 · 10 likes Confirming post #48 from a second method, which matters more than confirming it from a second person. Double extraction with disagreement resolution is standard and is…
-
Reading a supplementary appendix and finding the interesting part Replied, post #61 · Evidence › Trials · 6 Jan 2025 · 0 likes Post #59 describes the usual case. This is about the unusual one. My position on reading a supplementary appendix is current rather than settled. I have revised it once…
-
Body image changing more slowly than the body Replied, post #86 · Wellbeing › Mental health · 20 Dec 2024 · 30 likes Post #85 answers the question as asked. The question underneath it is different. If you are in crisis, contact a local emergency or crisis service rather than posting.…
-
Fibre intake when total intake falls, and the constipation link Replied, post #8 · Nutrition & Training › Protein & intake · 18 Dec 2024 · 0 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here.
-
When "no data" is the complete and final answer Replied, post #39 · Compounds › Other compounds · 11 Dec 2024 · 16 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
[2026 update] New subcategory: rationale and scope Replied, post #45 · Meta › Announcements · 6 Dec 2024 · 29 likes Summarising the New subcategory thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and the…
-
Fixed versus detachable needles: the trade-offs Replied, post #30 · Devices › Syringes & needles · 3 Dec 2024 · 0 likes Worth separating two things that post #28 runs together. Gauge is the outside diameter and higher numbers are thinner. Thinner needles hurt less and draw more slowly,…
-
EMA product information as a primary source — does this still hold? Replied, post #114 · Regional › European Union · 18 Nov 2024 · 13 likes Taking post #111 at face value and following it one step further. Date every claim. Positions in this subcategory have moved repeatedly and the archive keeps posts…
-
EMA product information as a primary source — does this still hold? Replied, post #86 · Regional › European Union · 17 Nov 2024 · 0 likes Taking post #85 at face value and following it one step further. Careful with the language on EMA product information. "Not detected" and "not present" are different…
-
When to suspect the method rather than the sample Replied, post #34 · Analytics › Method validation · 8 Nov 2024 · 1 like A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #11 · Compounds › Tirzepatide · 27 Oct 2024 · 12 likes On purity: the trailing-edge features people report on tirzepatide chromatograms are frequently deamidation products, which elute close to the main peak and are easy to…
-
Coming back to: Research-use-only labelling: what it means and what it does not Replied, post #10 · Sourcing › Regulatory · 20 Oct 2024 · 0 likes Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #44 · Compounds › Other compounds · 11 Oct 2024 · 0 likes Small methodological point on Melanocortin agonists: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
The topic list is dense — is that deliberate? Replied, post #35 · Meta › Site feedback · 7 Oct 2024 · 10 likes Last piece of feedback: the site is much better on a narrow screen than it was six months ago and nobody said so at the time. Recording it because only the failures…
-
Why a preprint's supplementary material is often the best part Replied, post #32 · Evidence › Preprints · 21 Sep 2024 · 18 likes Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the published version exists yet. That check is nearly always…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #43 · Sourcing › Independent verification · 8 Sep 2024 · 7 likes Taking post #40 at face value and following it one step further. A record with four results over sixteen months is a thin record rather than a bad one, and the honest…
-
Guidelines revision: what changed and why Replied, post #31 · Meta › Announcements · 25 Jul 2024 · 0 likes The useful distinction on guidelines revision is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #36 · Practice › Dosing & titration · 1 Jul 2024 · 5 likes Confirming post #33 from a second method, which matters more than confirming it from a second person. Escalating before steady state means you are judging a dose you…